Literature DB >> 31473332

Developmental origins of type 2 diabetes: Focus on epigenetics.

Alexander Vaiserman1, Oleh Lushchak2.   

Abstract

Traditionally, genetics and lifestyle are considered as main determinants of aging-associated pathological conditions. Accumulating evidence, however, suggests that risk of many age-related diseases is not only determined by genetic and adult lifestyle factors but also by factors acting during early development. Type 2 diabetes (T2D), an age-related disease generally manifested after the age of 40, is among such disorders. Since several age-related conditions, such as pro-inflammatory states, are characteristic of both T2D and aging, this disease is conceptualized by many authors as a kind of premature or accelerated aging. There is substantial evidence that intrauterine growth restriction (IUGR), induced by poor or unbalanced nutrient intake, exposure to xenobiotics, maternal substance abuse etc., may impair fetal development, thereby causing the fetal adipose tissue and pancreatic beta cell dysfunction. Consequently, persisting adaptive changes may occur in the glucose-insulin metabolism, including reduced capacity for insulin secretion and insulin resistance. These changes can lead to an improved ability to store fat, thus predisposing to T2D development in later life. The modulation of epigenetic regulation of gene expression likely plays a central role in linking the adverse environmental conditions early in life to the risk of T2D in adulthood. In animal models of IUGR, long-term persistent changes in both DNA methylation and expression of genes implicated in metabolic processes have been repeatedly reported. Findings from human studies confirming the role of epigenetic mechanisms in linking early-life adverse experiences to the risk for T2D in adult life are scarce compared to data from animal studies, mainly because of limited access to suitable biological samples. It is, however, convincing evidence that these mechanisms may also operate in human beings. In this review, theoretical models and research findings evidencing the role of developmental epigenetic variation in the pathogenesis of T2D are summarized and discussed.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging-related disease; DNA methylation; Developmental programming; Epigenetics; Intrauterine growth restriction; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31473332     DOI: 10.1016/j.arr.2019.100957

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  10 in total

Review 1.  Developmental Programming in Animal Models: Critical Evidence of Current Environmental Negative Changes.

Authors:  Victoria Ramírez; Regina J Bautista; Oswaldo Frausto-González; Nelly Rodríguez-Peña; Eduardo Tena Betancourt; Claudia J Bautista
Journal:  Reprod Sci       Date:  2022-06-13       Impact factor: 2.924

Review 2.  Developmental programming of insulin resistance: are androgens the culprits?

Authors:  Muraly Puttabyatappa; Robert M Sargis; Vasantha Padmanabhan
Journal:  J Endocrinol       Date:  2020-06       Impact factor: 4.286

3.  Profiling plasma-extracellular vesicle proteins and microRNAs in diabetes onset in middle-aged male participants in the ELSA-Brasil study.

Authors:  Laureane N Masi; Paulo A Lotufo; Frederico M Ferreira; Alice C Rodrigues; Tamires D A Serdan; Talita Souza-Siqueira; Aécio A Braga; Magda E G Saldarriaga; Tatiana C Alba-Loureiro; Fernanda T Borges; Diego P Cury; Mario H Hirata; Renata Gorjão; Tania C Pithon-Curi; Simão A Lottenberg; Ligia M G Fedeli; Helder T I Nakaya; Isabela J M Bensenor; Rui Curi; Sandro M Hirabara
Journal:  Physiol Rep       Date:  2021-02

Review 4.  Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis.

Authors:  Dagmara Kociszewska; Srdjan Vlajkovic
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 5.  Diagnostic and Therapeutic Roles of Extracellular Vesicles in Aging-Related Diseases.

Authors:  Zixuan Sun; Xiaomei Hou; Jiaxin Zhang; Jiali Li; Peipei Wu; Lirong Yan; Hui Qian
Journal:  Oxid Med Cell Longev       Date:  2022-08-08       Impact factor: 7.310

Review 6.  Early Life Exposure to Food Contaminants and Social Stress as Risk Factor for Metabolic Disorders Occurrence?-An Overview.

Authors:  Laurence Guzylack-Piriou; Sandrine Ménard
Journal:  Biomolecules       Date:  2021-05-03

Review 7.  Presbycusis: An Update on Cochlear Mechanisms and Therapies.

Authors:  Jing Wang; Jean-Luc Puel
Journal:  J Clin Med       Date:  2020-01-14       Impact factor: 4.241

8.  N1-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation.

Authors:  Jingfan Zhang; Yu Chen; Cong Liu; Ling Li; Ping Li
Journal:  J Diabetes Res       Date:  2020-03-23       Impact factor: 4.011

Review 9.  Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity.

Authors:  Jorge A Berlanga-Acosta; Gerardo E Guillén-Nieto; Nadia Rodríguez-Rodríguez; Yssel Mendoza-Mari; Maria Luisa Bringas-Vega; Jorge O Berlanga-Saez; Diana García Del Barco Herrera; Indira Martinez-Jimenez; Sandra Hernandez-Gutierrez; Pedro A Valdés-Sosa
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-16       Impact factor: 5.555

10.  Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis.

Authors:  Chenlu Zhang; Yuou Sha; Haiyan Liu; Dan Guo; Yijing Jiang; Lemin Hong; Lili Shi; Hongming Huang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.